Skip to main content
A

Ajanta Pharma Ltd. — Investor Relations & Filings

Ticker · AJANTPHARM ISIN · INE031B01049 LEI · 3358008XLYJJZBFBCK12 BSE.NS Manufacturing
Filings indexed 371 across all filing types
Latest filing 2025-02-05 Regulatory Filings
Country IN India
Listing BSE.NS AJANTPHARM

About Ajanta Pharma Ltd.

https://www.ajantapharma.com

Ajanta Pharma Ltd. is a specialty pharmaceutical organization engaged in the development, manufacturing, and marketing of high-quality finished dosage formulations. The company maintains a significant presence in specialized therapeutic segments, including ophthalmology, dermatology, cardiology, and pain management. It operates advanced research and development centers dedicated to creating complex generics and first-to-market products. With a global footprint, the firm serves diverse healthcare needs across the United States and various emerging markets in Asia and Africa. Its manufacturing infrastructure comprises multiple state-of-the-art facilities designed to meet international regulatory standards, ensuring the delivery of effective and affordable healthcare solutions. The company's strategic focus remains on niche product categories and branded generics, supported by a robust supply chain and a commitment to innovation in drug delivery systems.

Recent filings

Filing Released Lang Actions
Integrated Filing- Financial
Regulatory Filings
2025-02-05 English
Updates
Regulatory Filings
2025-02-05 English
Rumour Verification - Regulation 30(11)
Regulatory Filings
2025-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-03 English
Copy of Newspaper Publication
Regulatory Filings
2025-01-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.